Holen Sie sich die Stockscreener-App
0.6552
14.49%
-0.111
Schlusskurs vom Vortag:
$0.7662
Offen:
$0.7821
24-Stunden-Volumen:
2.12M
Relative Volume:
0.47
Marktkapitalisierung:
$43.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-86.08M
KGV:
-0.3037
EPS:
-2.1574
Netto-Cashflow:
$-72.06M
1W Leistung:
+18.67%
1M Leistung:
-61.68%
6M Leistung:
-23.82%
1J Leistung:
-45.85%
1-Tages-Spanne:
$0.62
$0.7856
1-Wochen-Bereich:
$0.55
$0.7856
52-Wochen-Spanne:
$0.3234
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Firmenname
Io Biotech Inc
Sektor
Branche
Telefon
(457) 070-2980
Adresse
OLE MAALOES VEH 3, COPENHAGEN
Vergleichen Sie IOBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.6552 | 50.48M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | Herabstufung | TD Cowen | Buy → Hold |
Io Biotech Inc Aktie (IOBT) Neueste Nachrichten
How IO Biotech Inc. stock reacts to bond yieldsSwing Trade & Risk Managed Investment Signals - Trung tâm Dự báo KTTV quốc gia
How IO Biotech Inc. stock reacts to global recession fearsJuly 2025 Fed Impact & Verified Chart Pattern Signals - Trung tâm Dự báo KTTV quốc gia
How hedge fund analytics apply to IO Biotech Inc. stockIPO Watch & Low Drawdown Investment Strategies - newser.com
Is IO Biotech Inc. stock near bottom after decline2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Key resistance and support levels for IO Biotech Inc.July 2025 Momentum & Community Supported Trade Ideas - newser.com
Can momentum traders help lift IO Biotech Inc.Treasury Yields & Fast Gaining Stock Reports - newser.com
Applying chart zones and confluence areas to IO Biotech Inc.Portfolio Gains Report & Risk Controlled Daily Plans - newser.com
Will IO Biotech Inc. stock outperform tech sector in 2025July 2025 PostEarnings & Precise Buy Zone Identification - newser.com
IO Biotech announces up to €57.5M debt financing from the European Investment Bank - MSN
Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Has IO Biotech Inc. found a price floorFed Meeting & AI Powered Buy and Sell Recommendations - newser.com
IO Biotech Inc. stock prediction for this weekMarket Volume Report & Weekly High Return Stock Forecasts - newser.com
Layoff Tracker: Ferring To Cut 500 Employees as Part of Business Model Shift - BioSpace
Candlestick signals on IO Biotech Inc. stock today2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
Does IO Biotech Inc. qualify in momentum factor screeningRisk Management & Verified Technical Signals - newser.com
Multi asset correlation models including IO Biotech Inc.Market Performance Recap & Growth Oriented Trading Recommendations - newser.com
Tick level data insight on IO Biotech Inc. volatilityEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion - Sahm
How sentiment analysis helps forecast IO Biotech Inc.Earnings Performance Report & Risk Managed Trade Strategies - newser.com
What does recent volatility data suggest for IO Biotech Inc.July 2025 Setups & Consistent Growth Equity Picks - newser.com
Analysts Set IO Biotech, Inc. (NASDAQ:IOBT) Price Target at $8.00 - Defense World
IO Biotech (NASDAQ:IOBT) Downgraded to Equal Weight Rating by Morgan Stanley - Defense World
IO Biotech’s (IOBT) Hold Rating Reaffirmed at TD Cowen - Defense World
IO Biotech (IOBT) Downgraded to Hold by TD Cowen | IOBT Stock Ne - GuruFocus
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says - MarketScreener
IO Biotech Feels The Heat As US FDA Dashes Cylembio Filing Hopes - insights.citeline.com
IO Biotech (NASDAQ:IOBT) Receives "Hold" Rating from TD Cowen - MarketBeat
TD Cowen Maintains IO Biotech(IOBT.US) With Hold Rating - 富途牛牛
TD Cowen Downgrades IO Biotech to Hold From Buy - MarketScreener
FDA Recommends Against IO Biotech’s Cylembio Application - The Globe and Mail
Finanzdaten der Io Biotech Inc-Aktie (IOBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):